Literature DB >> 11850131

Changing patient characteristics with increased methadone maintenance availability.

Bruna Brands1, Joan Blake, David Marsh.   

Abstract

Over the past several years there have been repeated calls for expansion of availability of methadone maintenance in several jurisdictions. Important stakeholders in the expansion of methadone maintenance treatment (MMT) are existing treatment providers. This study describes the impact of the rapid expansion in treatment availability in Ontario on the long-standing MMT program of the Centre for Addiction and Mental Health (CAMH). This expansion occurred through enlarging existing treatment programs, the provision of MMT in private physicians' offices and the establishment of new clinics. With expansion in the community, demand for the clinic-based treatment of the CAMH MMT program did not drop, in fact the patient population was able to continue to grow. There was a broadening of the patient profile in the program including patients who were better educated, more likely to be employed and less likely to be currently injecting (although with a significant history of past injection drug use). Moreover, in the face of these changes, excellent treatment retention was maintained. This suggests that the expansion in treatment availability did not impact negatively on the existing program but rather enabled access for a group of higher functioning opioid dependent patients who were previously being deterred from treatment entry by the large waiting lists and the need for priority access for pregnant and HIV positive heroin users. These findings should provide encouragement for MMT providers in jurisdictions anticipating or undergoing expansion of treatment availability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850131     DOI: 10.1016/s0376-8716(01)00176-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  11 in total

1.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

2.  Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis.

Authors:  Olga Morozova; Forrest W Crawford; Ted Cohen; A David Paltiel; Frederick L Altice
Journal:  Addiction       Date:  2019-10-29       Impact factor: 6.526

3.  Low vitamin d status of patients in methadone maintenance treatment.

Authors:  Theresa W Kim; Daniel P Alford; Michael F Holick; Alan O Malabanan; Jeffrey H Samet
Journal:  J Addict Med       Date:  2009-09       Impact factor: 3.702

4.  Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?

Authors:  Paul Kurdyak; Binu Jacob; Juveria Zaheer; Benedikt Fischer
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

5.  Nonmedical use of opioid analgesics among Ontario students.

Authors:  Bruna Brands; Angela Paglia-Boak; Beth A Sproule; Karen Leslie; Edward M Adlaf
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

6.  Client retention in the British Columbia Methadone Program, 1996-1999.

Authors:  John F Anderson; Leanne D Warren
Journal:  Can J Public Health       Date:  2004 Mar-Apr

7.  Socio-spatial stigmatization and the contested space of addiction treatment: remapping strategies of opposition to the disorder of drugs.

Authors:  Christopher B R Smith
Journal:  Soc Sci Med       Date:  2009-11-26       Impact factor: 4.634

8.  Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in British Columbia during its expansion period from 1998-2006.

Authors:  Behnam Sharif; Bohdan Nosyk; Huiying Sun; David C Marsh; Aslam Anis
Journal:  Subst Use Misuse       Date:  2013-06-10       Impact factor: 2.164

9.  Using poison center exposure calls to predict methadone poisoning deaths.

Authors:  Nabarun Dasgupta; Jonathan Davis; Michele Jonsson Funk; Richard Dart
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

10.  A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial.

Authors:  Eugenia Oviedo-Joekes; Kirsten Marchand; Kurt Lock; Jill Chettiar; David C Marsh; Suzanne Brissette; Aslam H Anis; Martin T Schechter
Journal:  Addict Sci Clin Pract       Date:  2014-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.